There have been considerable advances in the study of cancer cells that acquire resistance as a consequence of the repeated administration of anticancer drugs because such cells are frequently characterized by the overexpression of ABC proteins, which are crucial for drug efflux. This evidence concerns the gene ABCB6 and cancer.